| 发明名称 |
TREATMENT OF HORMONE-REFRACTORY PROSTATE CANCER |
| 摘要 |
A proportion of patients with hormone-refractory prostate cancer have great er survival times by treatment with DPPE, mitoxantrone and prednisone than patients receiving mitoxantrone and prednisone alone.
|
| 申请公布号 |
CA2429139(A1) |
申请公布日期 |
2004.10.30 |
| 申请号 |
CA20032429139 |
申请日期 |
2003.05.16 |
| 申请人 |
THE UNIVERSITY OF MANITOBA |
发明人 |
BRANDES, LORNE J. |
| 分类号 |
A61K31/122;A61K31/137;A61K31/138;A61K31/395;A61K31/573;A61P35/00;(IPC1-7):A61K31/138 |
主分类号 |
A61K31/122 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
